Durham University spin-out company Reinnervate, which is revolutionising the way cells are grown in the laboratory, is preparing for commercial manufacture and global sales after securing 750,000 pounds funding in a deal led by NorthStar Equity Investors (NSEI), a venture capital firm specialising in early-stage high-growth technologies.